コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 limp-1 (PRDM1), and X-box binding protein 1 (XBP1).
2 ranscription factor X-box binding protein 1 (XBP1).
3 ranscription factor X-box binding protein 1 (XBP1).
4 1alpha-dependent decay (RIDD) independent of XBP1.
5 transmembrane sensor IRE1 and its substrate XBP1.
6 nism that requires the transcription factor, XBP1.
7 emerge from Paneth-cell-specific deletion of Xbp1.
8 rogression, including TP53, BTG1, MKI67, and XBP1.
9 cing, occurring after depletion of unspliced XBP1.
11 tic inactivation of X-box binding protein-1 (Xbp1), a transcription factor activated during endoplasm
15 R1 mRNA expression and increased splicing of XBP1, a known IRE-alpha substrate, thereby pointing towa
16 rolysis of xylan are recognized and bound by XBP1, a putative solute-binding protein, likely for tran
17 canonical fibrogenic driver, suggesting that XBP1 activates a specific subset of fibrogenesis pathway
18 ddition, doxorubicin significantly inhibited XBP1 activation in CD138(+) tumor cells isolated from MM
19 A small molecule inhibitor of ERN1-mediated XBP1 activation induced selective cell death of patient-
20 icin as an in vitro and in vivo inhibitor of XBP1 activation, a previously unknown activity for this
22 show that SEC63 function regulates IRE1alpha/XBP1 activation, SEC63 and XBP1 are required for GPS cle
24 us protein (CHOP), X2-Box-binding protein 1 (XBP1), activator protein 1 (AP1), SMAD, CCAAT/enhancer-b
25 IRE1-signaling pathway, by expression of the XBP1-active form, compromised GCB DLBCL tumor growth in
31 olded protein response transcription factors XBP1 and CHOP nor the TLR4 adaptor molecule MyD88 is nec
32 ctor 6-mediated arm of this response through Xbp1 and downstream activation of the endoplasmic reticu
34 a mediator of these activities, and identify XBP1 and its splicing to be novel therapeutic targets.
35 10 genes selected by dwgLASSO, UBE2S, SALL2, XBP1 and KIAA0922 have been confirmed by literature surv
38 the activation loop show decreased specific Xbp1 and promiscuous RNase splicing activity relative to
41 through C-terminal domain with the unspliced XBP1 and the inositol requiring enzyme 1 alpha in the en
43 enotype, with suppression of Blimp, IRF4 and XBP1 and upregulation of BCL6, whereas introduction of p
44 ER Ca(2+) signaling; we show that diminished XBP1 and/or HNF4alpha in beta-cells led to impaired ER C
45 ), up-regulation of X-box-binding protein 1 (XBP1) and glucose-regulated protein 78 (GRP 78), and nuc
47 dent on the activity of transcription factor XBP1, and ANG promoted cellular adaptation to ER stress
50 n of multiple key factors, including Blimp1, Xbp1, and CXCR4, and is therefore critical for establish
51 mice, we found that PH induces expression of XBP1, and that this activity requires interleukin 6.
52 eukaryotic initiation factor 2alpha, nuclear XBP1, and the downstream proapoptotic effector nuclear C
53 gulates IRE1alpha/XBP1 activation, SEC63 and XBP1 are required for GPS cleavage and maturation of PC1
56 ion of the myc pathway and downregulation of XBP1 as likely mediators of the host transcriptional cha
57 the UPR pathway and its downstream effector XBP1 as novel therapeutic targets to overcome drug resis
58 s the mRNA encoding the transcription factor Xbp1 at a dual stem-loop (SL) structure, leading to Xbp1
61 notype, marked by induction of the IRE1alpha/XBP1 axis of the unfolded protein response (UPR) and cul
62 issue showed that at 6 hours after PH, liver XBP1 became bound to a large set of genes implicated in
67 Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and indicate that targeti
68 ith its inhibitory activity on the IRE1alpha-XBP1 branch of the UPR, doxorubicin displayed more poten
69 ficiency selectively activates the IRE1alpha-XBP1 branch of UPR and that SEC63 exists in a complex wi
70 ed by ER stress and X-box-binding protein 1 (XBP1) but not by activating transcription factor 6 alpha
71 ne expression is induced during ER stress by XBP1, but as ER stress subsides, MIST1 serves as a feedb
72 nd that ablation of the transcription factor XBP1, but not ATF4, significantly delay locomotor recove
76 age and maturation of PC1, and activation of XBP1 can protect against polycystic disease in the setti
77 rence, we solved the co-crystal structure of XBP1 complexed with xylotriose to a 1.8-A resolution.
80 XBP1 (X-box binding protein-1) floxed mice (XBP1-conditional knockout), with antibody-mediated deple
81 mediators, such as X-box-binding protein 1 (XBP1), confer genetic risk for inflammatory bowel diseas
82 f XBP1 increased, whereas siRNA knockdown of XBP1 considerably reduced, PRNP and ERLEC1 mRNA levels i
83 , Cre-mediated deletion of Hspa5, Prdm1, and Xbp1 consistently induces cellular stress and cell death
86 anscription factor, X-box-binding protein-1 (XBP1), controls the development and maintenance of the e
87 l knock-out (XBP1eko) mice demonstrated that XBP1 deficiency in ECs reduced the basal level of LC3bet
89 with hindlimb ischemia models revealed that XBP1 deficiency in SMCs significantly attenuated angioge
95 CReP expression was markedly suppressed in XBP1-deficient mice livers due to hyperactivated IRE1alp
99 Here we show that impairment in either UPR (Xbp1(DeltaIEC)) or autophagy function (Atg16l1(DeltaIEC)
101 her, our findings provide a new paradigm for XBP1-dependent UPR regulation and position MIST1 as a po
103 -induced autophagy response, whereas spliced XBP1 did not induce transcriptional activation of a trun
106 s downstream target X-box-binding protein 1 (XBP1) drive B-cell differentiation toward plasma cells a
107 scriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcri
108 Importantly, data from arterial vessels from XBP1 EC conditional knock-out (XBP1eko) mice demonstrate
111 Concomitant inactivation of both SEC63 and XBP1 exacerbated the polycystic kidney phenotype in mice
120 -specific Xbp1 knockout mice (Xbp1(LKO)) and Xbp1(fl/fl) control mice were subjected to varying level
123 lator of the UPR master transcription factor XBP1 for a portion of target genes that contain adjacent
126 ts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlate
127 nitored by measuring HSPA5, CHOP and spliced XBP1 gene expression, and type I IFN by measuring IFNB1
130 s patients, we observed up-regulation of the XBP1-Hrd1 arm of the ER stress response pathway and down
135 ignaling activities of spliced and unspliced XBP1 in breast cancer, establish NF-kappaB to be a media
136 on in various human tumours, but the role of XBP1 in cancer progression in mammary epithelial cells i
137 expression of Grp78, ATF6, ATF4, and spliced XBP1 in CD8alphabeta(+) IEL but not in CD8alphaalpha(+)
139 data support an important intrinsic role for XBP1 in DC for effective cross-priming and orchestration
140 tedly selective and absolute requirement for XBP1 in eosinophil differentiation without an effect on
144 This study reveals an unexpected role for Xbp1 in suppressing tumor formation through restraint of
147 Here we show that constitutive activation of XBP1 in tumor-associated DCs (tDCs) drives ovarian cance
148 Cell, Cubillos-Ruiz et al. demonstrate that XBP1 in tumor-infiltrating dendritic cells blunts anti-t
149 ranscription factor X box-binding protein 1 (XBP1) in DC appears to play a decisive role in promoting
150 ranscription factor X-box binding protein-1 (Xbp1) in intestinal epithelial cells, the human ortholog
151 ranscription factor X-box binding protein 1 (XBP1) in liver regeneration using genome-wide chromatin
152 pmental ablation of X-Box binding protein 1 (XBP1) in the nervous system, a key regulator of the unfo
156 BECLIN-1 deficiency in ECs abolished the XBP1-induced autophagy response, whereas spliced XBP1 di
157 These findings suggest that the loss of Xbp1 induces a terminal UPR which blocks proliferation a
160 breast cancer cell line models, depletion of XBP1 inhibited tumour growth and tumour relapse and redu
167 and activity of the UPR downstream effector XBP1 is regulated positively by STAT5 and negatively by
170 ranscription factor X-box-binding protein 1 (XBP1), is increased following exposure of melanocytes to
171 ion assays further revealed that the spliced XBP1 isoform bound directly to the BECLIN-1 promoter at
172 kout [alphaXBPKO] mice) and in vitro (stable XBP1 knockdown alpha-cell line [alphaXBPKD]) models.
175 d complementary in vivo (alpha-cell-specific XBP1 knockout [alphaXBPKO] mice) and in vitro (stable XB
177 requiring enzyme 1, an upstream activator of XBP1, leading to phosphorylation of Jun NH2-terminal kin
178 ucing RAW 264.7 cells with the short hairpin XBP1 lentiviral vector significantly reduced the parasit
179 1alpha also cleaves certain mRNAs containing XBP1-like secondary structures to promote the degradatio
180 t during acute ER stress in mammalian cells, Xbp1-like SLs within the target mRNAs are necessary for
184 ignalling via the insulin receptor, p85, and XBP1 maintains podocyte homeostasis, while disruption of
185 14-3-3gamma, Ywhab/14-3-3beta, Smad5, Zfp36, Xbp1, Mapk12, Snail1) were experimentally validated by i
186 demonstrated a crucial role for the IREalpha/XBP1-mediated arm of the UPR in osteoclast differentiati
188 ha/X-box-binding protein-mediated (IRE1alpha/XBP1-mediated) branch of the UPR is highly conserved and
189 g the mRNA encoding the transcription factor Xbp1, mediates mRNA degradation in response to ER stress
191 n-conventional splicing of Hac1 (yeasts) and XBP1 (metazoans) mRNA, encoding orthologous UPR transcri
192 ate in the sequence-specific splicing of the Xbp1 mRNA and in the regulated degradation of diverse me
193 ng isoform had significantly less BLIMP1 and XBP1 mRNA and, for human pre-B cells, remained CD138 neg
194 initiated by unconventional splicing of HAC1/XBP1 mRNA during endoplasmic reticulum (ER) stress.
195 ads to unconventional, enzymatic splicing of XBP1 mRNA enabling expression of the transcription facto
197 rials for children and adults with ALL, high XBP1 mRNA levels at the time of diagnosis predicted poor
198 ions: tRNA ligation after intron removal and XBP1 mRNA ligation during activation of the unfolded pro
199 E1alpha promotes adaptation through splicing Xbp1 mRNA or apoptosis through incompletely understood m
202 activated autophagic gene expression through XBP1 mRNA splicing in an inositol-requiring enzyme 1alph
204 cing (mRNA-Seq), we show that unconventional Xbp1 mRNA splicing is required to increase and decrease
205 The present study provides evidence that XBP1 mRNA splicing triggered an autophagic response in E
207 requiring enzyme 1 alpha phosphorylation and XBP1 mRNA splicing, which was abolished by siRNA-mediate
209 (RNase), a key mediator of the UPR, cleaves Xbp1 mRNA to generate a potent transcription factor adap
210 d the endoribonuclease IRE1alpha and spliced Xbp1 mRNA without inducing parallel endoplasmic reticulu
211 ositive, demonstrated upregulated BLIMP1 and XBP1 mRNA, and acquired the morphology of plasma cells.
212 phosphorylation of IRE1alpha and splicing of XBP1 mRNA, resulting in exaggerated upregulation of UPR
213 he UPR, senses misfolded protein and cleaves XBP1 mRNA, which is ligated to code for the prosurvival
216 nisomycin inhibited X-box-binding protein 1 (XBP1) mRNA splicing and reduced immunoglobulin-binding p
218 n the 3' UTR of the X-box binding protein 1 (XBP1) mRNA that regulates its cytoplasmic splicing and s
219 pecific cleavage of X-box binding protein 1 (XBP1) mRNA, resulting in upregulation of the unfolded pr
220 activated to splice X-box binding protein 1 (XBP1) mRNA, thereby increasing XBP1s protein, which in t
221 6, BiP, Cyclin B2, OcaB (BOB1, Pou2af1), and XBP1 mRNAs, unspliced and spliced, are severely reduced
224 xplored the role of X-box binding protein 1 (XBP1), one of three UPR effector pathways and sought to
228 ed that either overexpression of the spliced XBP1 or treatment with platelet derived growth factor-BB
229 Schizosaccharomyces pombe lacks both a Hac1/XBP1 ortholog and a UPR-dependent-transcriptional-progra
230 leavage of PC1 in SEC63-deficient cells, and XBP1 overexpression in vivo ameliorated cystic disease i
232 stogenesis, and suppression of the IRE1alpha/XBP1 pathway in these cells substantially inhibited the
233 In this study, we examined whether IRE1alpha-XBP1 pathway is a potential therapeutic target in MM usi
234 ctively, our results indicate that an intact Xbp1 pathway operating to mitigate stress in the endopla
237 We conclude thatL. amazonensisactivation of XBP1 plays a critical role in infection by protecting th
239 amers against a structured RNA, derived from XBP1 pre-mRNA, that folds as two contiguous hairpins.
240 s a feedback inhibitor, directly binding the Xbp1 promoter and repressing Xbp1 transcript production.
241 lasmic reticulum (ER) stress response factor XBP1 promotes intrinsic tumor growth directly, but wheth
242 g, gene therapy to deliver an active form of XBP1 provided neuroprotection and reduced striatal dener
244 s demonstrated an increased spliced-to-total Xbp1 ratio, whereas SERCA2b overexpression reduced the X
246 We demonstrate here that genetic ablation of XBP1 results in constitutive IRE1alpha activation in the
247 ained activation of X-box-binding protein 1 (XBP1) results in endothelial cell (EC) apoptosis and ath
249 ers showing increased expression of CHOP and XBP1 RNAs, and PERK and BIP proteins, but not XBP1 splic
250 rms regulate NF-kappaB activity via ERalpha; XBP1(S) is more potent because it also directly regulate
253 form [XBP1(U)] and the spliced active form [XBP1(S)], is a key UPR component mediating antiestrogen
255 deletion or selective nanoparticle-mediated XBP1 silencing in tDCs restored their immunostimulatory
256 essive decline in hepatic IRE1alpha-mediated XBP1 splicing activity in both genetic (ob/ob) and dieta
258 ein (BiP) levels, whereas BAPTA-AM increased XBP1 splicing and BiP expression, suggesting that ER cal
259 esistant variant restored IRE1alpha-mediated XBP1 splicing and improved glucose homeostasis in vivo.
261 er, our results demonstrate that blockade of XBP1 splicing by inhibition of IRE1alpha endoribonucleas
266 te that glucose activates IRE1alpha-mediated Xbp1 splicing to expand the secretory capacity of the be
268 bit both chemical and bacterial induction of XBP1 splicing via bacterial translocated proteins that i
269 la Rtca and Archease had opposing effects on Xbp1 splicing, and deficiency of Archease or Xbp1 impede
270 on elongation inhibitors was unable to block XBP1 splicing, but this could be rescued by expression o
271 to the pathogen was ineffective in blocking XBP1 splicing, demonstrating the need for the elongation
272 locked pattern recognition receptor-mediated XBP1 splicing, mimicking the effects of the bacterial tr
273 BLOC1S1 cleavage is temporally separate from XBP1 splicing, occurring after depletion of unspliced XB
282 tly represses expression of PRDM1, IRF4, and XBP1, transcriptional master regulators of plasma cell (
283 nd nonspliceable forms of XBP1, we show that XBP1(U) functions beyond being a dominant negative of XB
284 e transcriptionally inactive unspliced form [XBP1(U)] and the spliced active form [XBP1(S)], is a key
286 that LPS activates the transcription factor XBP1 via the ER stress sensor IRE1, resulting in the ind
291 ing novel spliced and nonspliceable forms of XBP1, we show that XBP1(U) functions beyond being a domi
293 riptional relationship between HNF4alpha and Xbp1 with potentially broader implications about MODYI a
294 pathway of the UPR and governs expression of XBP1 (X-box binding protein 1), a key transcription fact
295 body deficiency, B cell-specific CD79a-Cre x XBP1 (X-box binding protein-1) floxed mice (XBP1-conditi
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。